                         SEQUENCE LISTING

<110>  KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
       Bossmann, Stefan H.
       Troyer, Deryl L.
       Basel, Matthew T.
       Shrestha, Tej B.
       Wang, Hongwang
 
<120>  PROTEASE SELECTIVE SUPRAMOLECULAR ASSEMBLIES

<130>  Docket No. 42359-PCT

<150>  US 61/387,870
<151>  2010-09-29

<160>  73    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Homo sapiens

<400>  1

Ser Gly Arg Ser Ala 
1               5   


<210>  2
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  2

Val Pro Met Ser Met Arg Gly Gly 
1               5               


<210>  3
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  3

Ile Pro Val Ser Leu Arg Ser Gly 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  4

Arg Pro Phe Ser Met Ile Met Gly 
1               5               


<210>  5
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  5

Val Pro Leu Ser Leu Thr Met Gly 
1               5               


<210>  6
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  6

Val Pro Leu Ser Leu Tyr Ser Gly 
1               5               


<210>  7
<211>  31
<212>  PRT
<213>  Homo sapiens

<400>  7

His Gly Pro Glu Gly Leu Arg Val Gly Phe Tyr Glu Ser Asp Val Met 
1               5                   10                  15      


Gly Arg Gly His Ala Arg Leu Val His Val Glu Glu Pro His Thr 
            20                  25                  30      


<210>  8
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  8

Gly Ala Ala Asn Leu Val Arg Gly 
1               5               


<210>  9
<211>  12
<212>  PRT
<213>  Homo sapiens

<400>  9

Gly Pro Gln Gly Leu Ala Gly Gln Arg Gly Ile Val 
1               5                   10          


<210>  10
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  10

Ile Pro Glu Ser Leu Arg Ala Gly 
1               5               


<210>  11
<211>  12
<212>  PRT
<213>  Homo sapiens

<400>  11

Ser Leu Leu Lys Ser Arg Met Val Pro Asn Phe Asn 
1               5                   10          


<210>  12
<211>  4
<212>  PRT
<213>  Homo sapiens

<400>  12

Asp Ala Phe Lys 
1               


<210>  13
<211>  12
<212>  PRT
<213>  Homo sapiens

<400>  13

Ser Leu Leu Ile Phe Arg Ser Trp Ala Asn Phe Asn 
1               5                   10          


<210>  14
<211>  10
<212>  PRT
<213>  Homo sapiens

<400>  14

Ser Gly Lys Pro Ile Leu Phe Phe Arg Leu 
1               5                   10  


<210>  15
<211>  11
<212>  PRT
<213>  Homo sapiens

<400>  15

Ser Gly Ser Pro Ala Phe Leu Ala Lys Asn Arg 
1               5                   10      


<210>  16
<211>  10
<212>  PRT
<213>  Homo sapiens

<400>  16

Ser Gly Lys Pro Ile Ile Phe Phe Arg Leu 
1               5                   10  


<210>  17
<211>  5
<212>  PRT
<213>  Homo sapiens

<400>  17

Pro Arg Ala Gly Ala 
1               5   


<210>  18
<211>  12
<212>  PRT
<213>  Homo sapiens

<400>  18

Ser Gly Val Val Ile Ala Thr Val Ile Val Ile Thr 
1               5                   10          


<210>  19
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  19

Gly Pro Leu Gly Met Leu Ser Gln 
1               5               


<210>  20
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  20

Gly Ser Gly Arg Ser Ala Gly Cys 
1               5               


<210>  21
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  21

Gly Ser Gly Arg Ser Ala Gly Lys 
1               5               


<210>  22
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  22

Lys Gly Gly Gly Ser Gly Arg Ser Ala Gly Gly Gly Cys 
1               5                   10              


<210>  23
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  23

Cys Gly Gly Gly Ser Gly Arg Ser Ala Gly Gly Cys 
1               5                   10          


<210>  24
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  24

Cys Gly Gly Gly Ser Gly Arg Ser Ala Gly Gly Gly Cys 
1               5                   10              


<210>  25
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  25

Asp Gly Gly Ser Gly Arg Ser Ala Gly Gly Lys 
1               5                   10      


<210>  26
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  26

Ser Arg Ser Arg Ser Arg Ser Arg Ser Arg Ser Gly Arg Ser Ala Gly 
1               5                   10                  15      


Gly Gly Cys 
            


<210>  27
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  27

Lys Gly Gly Ser Gly Arg Ser Ala Gly Gly Asp 
1               5                   10      


<210>  28
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  28

Cys Gly Gly Gly Ser Gly Arg Ser Ala Gly Gly Gly 
1               5                   10          


<210>  29
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  29

Asp Gly Gly Gly Ser Gly Arg Ser Ala Gly Gly Gly Asp 
1               5                   10              


<210>  30
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  30

Asp Gly Ala Gly Ser Gly Arg Ser Ala Gly Ala Gly Asp 
1               5                   10              


<210>  31
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  31

Lys Gly Gly Ser Gly Arg Ser Ala Gly Gly Gly 
1               5                   10      


<210>  32
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  32

Asp Gly Gly Ser Gly Arg Ser Ala Gly Gly Gly Cys 
1               5                   10          


<210>  33
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  33

His His His Gly Ala Gly Ser Gly Arg Ser Ala Gly Ala Gly 
1               5                   10                  


<210>  34
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  34

Lys Gly Gly Val Pro Met Ser Met Arg Gly Gly Gly Cys 
1               5                   10              


<210>  35
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  35

His His His Gly Ala Gly Val Pro Met Ser Met Arg Gly Ala Gly 
1               5                   10                  15  


<210>  36
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  36

Lys Gly Gly Ile Pro Val Ser Leu Arg Ser Gly Gly Cys 
1               5                   10              


<210>  37
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  37

His His His Gly Ala Gly Ile Pro Val Ser Leu Arg Ser Gly Ala Gly 
1               5                   10                  15      


<210>  38
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  38

His His His Gly Ala Gly Arg Pro Phe Ser Met Ile Met Gly Ala Gly 
1               5                   10                  15      


<210>  39
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  39

Lys Gly Gly Val Pro Leu Ser Leu Thr Met Gly Gly Cys 
1               5                   10              


<210>  40
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  40

His His His Gly Ala Gly Val Pro Leu Ser Leu Thr Met Gly Ala Gly 
1               5                   10                  15      


<210>  41
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  41

His His His Gly Ala Gly Val Pro Leu Ser Leu Tyr Ser Gly Ala Gly 
1               5                   10                  15      


<210>  42
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  42

His His His Gly Ala Gly Gly Ala Ala Asn Leu Val Arg Gly Gly Ala 
1               5                   10                  15      


Gly 
    


<210>  43
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  43

His His His Gly Ala Gly Pro Gln Gly Leu Ala Gly Gln Arg Gly Ile 
1               5                   10                  15      


Val Gly Ala Gly 
            20  


<210>  44
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  44

His His His Gly Ala Gly Ser Leu Leu Lys Ser Arg Met Val Pro Asn 
1               5                   10                  15      


Phe Asn Gly Ala Gly 
            20      


<210>  45
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  45

His His His Gly Ala Gly Ser Leu Leu Ile Phe Arg Ser Trp Ala Asn 
1               5                   10                  15      


Phe Asn Gly Ala Gly 
            20      


<210>  46
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  46

His His His Gly Ala Gly Ser Gly Val Val Ile Ala Thr Val Ile Val 
1               5                   10                  15      


Ile Thr Gly Ala Gly 
            20      


<210>  47
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide linkage with protease consensus sequence.

<400>  47

His His His Gly Ala Gly Pro Arg Ala Gly Ala Gly 
1               5                   10          


<210>  48
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  48

Cys Arg Gly Asp Lys Gly Pro Asp Cys 
1               5                   


<210>  49
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  49

Lys Asp Glu Pro Gln Arg Arg Ser Ala Arg Leu Ser Ala Lys Pro Ala 
1               5                   10                  15      


Pro Pro Lys Pro Glu Pro Lys Pro Lys Lys Ala Pro Ala Lys Lys 
            20                  25                  30      


<210>  50
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  50

Cys Gly Asn Lys Arg Thr Arg Gly Cys 
1               5                   


<210>  51
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  51

His Ala Ile Tyr Pro Arg His 
1               5           


<210>  52
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  52

Ala Thr Trp Leu Pro Pro Arg 
1               5           


<210>  53
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  53

Arg Arg Lys Arg Arg Arg 
1               5       


<210>  54
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  54

Glu Glu Glu Ala Ala Gly Arg Lys Arg Lys Lys Arg Thr 
1               5                   10              


<210>  55
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is 3,5 diiodotyrosine

<400>  55

Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Xaa Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210>  56
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is 3,5 diiodotyrosine

<400>  56

Trp Glu Ala Ala Leu Ala Glu Ala Leu Ala Glu Ala Leu Ala Xaa His 
1               5                   10                  15      


Leu Ala Ala Leu Ala Glu Ala Leu Glu Ala Leu Ala Ala 
            20                  25                  


<210>  57
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  57

Ala Pro Ser Pro Met Ile Trp 
1               5           


<210>  58
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  58

Leu Gln Asn Ala Pro Arg Ser 
1               5           


<210>  59
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  59

Cys Gly Leu Ile Ile Gln Lys Asn Glu Cys 
1               5                   10  


<210>  60
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  60

Cys Asn Ala Gly Glu Ser Ser Lys Asn Cys 
1               5                   10  


<210>  61
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  61

Cys Arg Glu Lys Ala 
1               5   


<210>  62
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  62

Cys Gly Lys Arg Lys 
1               5   


<210>  63
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  63

Cys Gly Ser Leu Val Arg Cys 
1               5           


<210>  64
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  64

Cys Pro Gly Pro Glu Gly Ala Gly Cys 
1               5                   


<210>  65
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  65

Cys Asp Thr Arg Leu 
1               5   


<210>  66
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  66

Arg Arg Pro Tyr Ile Leu 
1               5       


<210>  67
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  67

Glu Asp Tyr Glu Leu Met Asp Leu Leu Ala Tyr Leu 
1               5                   10          


<210>  68
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  68

Ala Thr Trp Leu Pro Pro Arg 
1               5           


<210>  69
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  69

Cys Gly Gly Lys Leu Lys Ser Gln Leu Val Lys Arg Lys 
1               5                   10              


<210>  70
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  70

Cys Gly Gly Lys Asn Gly Arg Tyr Ser Ile Ser Arg 
1               5                   10          


<210>  71
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  71

Cys Gly Gly Arg Asp Gly Thr Arg Tyr Val Gln Lys Gly Glu Tyr Arg 
1               5                   10                  15      


<210>  72
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  72

Cys Gly Gly Ala His Trp Gln Phe Asn Ala Leu Thr Val Arg 
1               5                   10                  


<210>  73
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic tumor-homing peptide

<400>  73

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln Cys 
1               5                   10              


